These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30891618)

  • 41. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-202 expression concentration and its clinical significance in the serum of multiple myeloma patients.
    Yu J; Qiu X; Shen X; Shi W; Wu X; Gu G; Zhu B; Ju S
    Ann Clin Biochem; 2014 Sep; 51(Pt 5):543-9. PubMed ID: 24048721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating MicroRNA-92b-3p as a Novel Biomarker for Monitoring of Synovial Sarcoma.
    Uotani K; Fujiwara T; Yoshida A; Iwata S; Morita T; Kiyono M; Yokoo S; Kunisada T; Takeda K; Hasei J; Numoto K; Nezu Y; Yonemoto T; Ishii T; Kawai A; Ochiya T; Ozaki T
    Sci Rep; 2017 Nov; 7(1):14634. PubMed ID: 29116117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel serum microRNA-based identification and classification biomarker of human glioma.
    Xing W; Zeng C
    Tumour Biol; 2017 May; 39(5):1010428317705339. PubMed ID: 28475008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia.
    Liu K; Xuekelati S; Zhang Y; Yin Y; Li Y; Chai R; Li X; Peng Y; Wu J; Guo X
    BMC Cardiovasc Disord; 2017 Jun; 17(1):163. PubMed ID: 28633641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
    Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
    Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expressions of miR-181a and miR-20a in RPMI8226 cell line and their potential as biomarkers for multiple myeloma.
    Peng J; Thakur A; Zhang S; Dong Y; Wang X; Yuan R; Zhang K; Guo X
    Tumour Biol; 2015 Nov; 36(11):8545-52. PubMed ID: 26032093
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The diagnostic and prognostic values of circulating miRNA-1246 in multiple myeloma.
    Zhao G; Jing X; Li Z; Wu X; Gao Z; Ma R
    Hematology; 2022 Dec; 27(1):778-784. PubMed ID: 35793786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.
    Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M
    J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway.
    Feng Y; Zhang L; Wu J; Khadka B; Fang Z; Gu J; Tang B; Xiao R; Pan G; Liu J
    J Exp Clin Cancer Res; 2019 Feb; 38(1):54. PubMed ID: 30728056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-Level Expression of microRNA-21 in Peripheral Blood Mononuclear Cells Is a Diagnostic and Prognostic Marker in Prostate Cancer.
    Huang W; Kang XL; Cen S; Wang Y; Chen X
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):469-75. PubMed ID: 26247873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
    Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
    Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
    Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
    Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum miR-29a as a marker of multiple myeloma.
    Sevcikova S; Kubiczkova L; Sedlarikova L; Slaby O; Hajek R
    Leuk Lymphoma; 2013 Jan; 54(1):189-91. PubMed ID: 22712836
    [No Abstract]   [Full Text] [Related]  

  • 58. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
    Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
    Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
    Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
    Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
    Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.